Revenio Group Oyj

Equities

REG1V

FI0009010912

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Helsinki 11:29:38 2024-04-24 am EDT 5-day change 1st Jan Change
24.98 EUR -2.12% Intraday chart for Revenio Group Oyj -1.50% -8.03%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Revenio Group Corporation Announces Composition of Nomination and Remuneration Committee CI
Revenio Group Corporation Approves Dividend, Payable on April 15, 2024 CI
Revenio Group Oyj Proposes Dividend for the Year Ended December 31, 2023, Payable on April 15, 2024 CI
Transcript : Revenio Group Oyj, 2023 Earnings Call, Feb 15, 2024
Revenio Group Oyj to Propose Dividend CI
Revenio Group Oyj Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Revenio Group Oyj Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Revenio Unit, iCare Enter Partnership Deal for AI Retinal Screening Service MT
Revenio Group Seeks M&A Opportunities CI
Transcript : Revenio Group Oyj - Analyst/Investor Day
Transcript : Revenio Group Oyj, Q3 2023 Earnings Call, Oct 26, 2023
Revenio Group Oyj Provides Earnings Guidance for the Year 2023 CI
Revenio Group Oyj Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Transcript : Revenio Group Oyj, H1 2023 Earnings Call, Aug 10, 2023
Revenio Group Oyj Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Revenio Group Corporation Expands the Ai-Aided iCare Illume Screening Solution's Applications CI
Revenio, OphtAI Enter Distribution Partnership for Retinal Image Analysis MT
Transcript : Revenio Group Oyj, Q1 2023 Earnings Call, Apr 27, 2023
Revenio Group Oyj Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Revenio Group Oyj Approves Dividend for the Year Ended December 31, 2022, Payable on April 3, 2023 CI
Revenio Group Oyj Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
Transcript : Revenio Group Oyj, 2022 Earnings Call, Feb 09, 2023
Revenio Group Oyj Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Revenio Group Oyj Proposes Dividend for the Year Ended December 31, 2022 CI
Revenio Seeks Acquisitions CI
Chart Revenio Group Oyj
More charts
Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based company primarily engaged in the health technology segment. The Company’s activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material handling systems. It distributes products in a range of countries, including the United States, Canada, Australia, Japan and India. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
24.98 EUR
Average target price
29.06 EUR
Spread / Average Target
+16.33%
Consensus
  1. Stock Market
  2. Equities
  3. REG1V Stock
  4. News Revenio Group Oyj
  5. Revenio, OphtAI Enter Distribution Partnership for Retinal Image Analysis